+ Watch FHCO
on My Watchlist
The Female Health Company engages in the manufacture, marketing, and distribution of the female condom.
Unless they add new products I don't see a demand for this product. Regular condoms, pills and injections is the norm, much more convienent. This product doesn't address current conusmers needs. Just another novelty. Growth is looking slim.
You will notice that FHCO has followed a very different trajectory than you expected. I think the error here is that FHCO isn't really dependent on the market in general, and to understand this company/stock you can't be myopic and look at it through the lens of what the U.S. or other developed countries need. I'm not sure who the "current consumer" is that you refer. FHCO is targeted toward women/families in the developing world, where "pills and injections" are not, as you suggest, the norm.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions